aTyr Pharma (ATYR) Q4 2024 Annual Earnings
ATYR·Reported March 13, 2025·After market close
Diluted EPS came in at $-0.18, beat the $-0.23 consensus by $0.05.
Diluted EPS
$-0.18beat by $0.05
Consensus: $-0.23
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about aTyr Pharma's Q4 2024 earnings report.
aTyr Pharma (ATYR) reported Q4 2024 earnings on March 13, 2025 after market close.
aTyr Pharma reported diluted EPS of $-0.18 for Q4 2024.
EPS beat the consensus estimate of $-0.23 by $0.05.
You can read the 10-K periodic report (0000950170-25-038888) directly on SEC EDGAR. The filing index links above go to sec.gov.